Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of...
Transcript of Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of...
![Page 1: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/1.jpg)
Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome
Christophe Rosty
Brisbane, QLD, Australia
![Page 2: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/2.jpg)
F 78 – Positive FOBT – Extended right hemicolectomy
Tumour 3
Tumour 2Tumour 1
![Page 3: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/3.jpg)
Tumour 3Tumour 2Tumour 1
![Page 4: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/4.jpg)
Tumour 3Tumour 2Tumour 1MLH1 MLH1 MLH1
![Page 5: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/5.jpg)
18 polyps up to 21 mm in size
![Page 6: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/6.jpg)
Sessile serrated polyp/lesion (SSP)
![Page 7: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/7.jpg)
Sessile serrated polyp/lesion with dysplasia (SSPD)
![Page 8: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/8.jpg)
Risk of CRC in serrated polyposis patients?
![Page 9: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/9.jpg)
Risk of CRC in serrated polyposis patients?
• Two large retrospective studies from Europe
• CRC in 16-29% of SPosis patients
• Majority of CRC at or before the diagnosis of SPosis
• Nearly 50% are from rectosigmoid
• Risk factors for CRC:• Phenotype 1 + 2
• > 2 SSPs proximal to splenic flexure
• 1 SSP with dysplasia
• 1 advanced conventional adenoma
Carballal et al. Gut 2016; 65:1829-1837Ijspeert JEG et al. Gut 2017; 66:278-284
![Page 10: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/10.jpg)
Serrated neoplasia pathway CRC
![Page 11: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/11.jpg)
Microvesicular HP
SSP
Normal colonic mucosa
BRAF mutation
BRAF serrated pathway
![Page 12: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/12.jpg)
Microvesicular HP
SSP BRAF-mutated TSA
Normal colonic mucosa
BRAF mutation
BRAF mutationCIMP
BRAF serrated pathway
![Page 13: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/13.jpg)
Microvesicular HP
SSP BRAF-mutated TSA
Normal colonic mucosa
Goblet cell HP
KRAS-mutated TSA
BRAF mutation
BRAF mutationCIMP
KRAS mutation
BRAF serrated pathway KRAS serrated pathway
![Page 14: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/14.jpg)
Microvesicular HP
SSP
MLH1-deficient SSP with dysplasia
BRAF-mutated MMR-deficient CRC
Normal colonic mucosa
BRAF mutation
CIMP-H
MLH1 methylationWNT activation
BRAF serrated pathway
75%
![Page 15: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/15.jpg)
SSP
SSPD
Carcinoma
![Page 16: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/16.jpg)
SSPSSPD
Carcinoma – 6mm lesion
![Page 17: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/17.jpg)
Microvesicular HP
SSP
BRAF-mutated MMR-proficient CRC
Normal colonic mucosa
MLH1-proficient SSP with dysplasia
BRAF mutation
CIMP-H
BRAF serrated pathway
WNT activationTP53 mutation
25%
![Page 18: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/18.jpg)
Microvesicular HP
SSP
BRAF-mutated MMR-proficient CRC
Normal colonic mucosa
MLH1-proficient SSP with dysplasia
BRAF mutation
CIMP-H
BRAF serrated pathway
WNT activationTP53 mutation
BRAF-mutated MMR-proficient CRC
BRAF-mutated TSA
BRAF-mutated TSA with high grade dysplasia
BRAF mutationCIMP
WNT activationTP53 mutation
![Page 19: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/19.jpg)
SSP
SSPD
Carcinoma
![Page 20: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/20.jpg)
Carcinoma
![Page 21: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/21.jpg)
MLH1 retained
![Page 22: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/22.jpg)
Carcinoma
SSP SSPD
![Page 23: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/23.jpg)
Compared with SSP with MLH1-deficient dysplasia/carcinoma, MLH1-proficient dysplasia/carcinoma:
➢ More frequent in men (64% vs 30%)
➢ In younger patients (71 y vs 76.7 y)
➢ Less often in proximal colon (72% vs 91%)
➢ Less often CIMP-high (80% vs 98%)
➢ More p53 aberrant expression (34% vs 7%)
Bettington et al. Gut 2017;66:97-106.
![Page 24: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/24.jpg)
KRAS-mutated MMR-proficient CRC
KRAS-mutated TSA with high grade dysplasia
Normal colonic mucosa
Goblet cell HP
KRAS-mutated TSA
KRAS mutation
KRAS serrated pathway
CIMP-L
WNT activationTP53 mutation
![Page 25: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/25.jpg)
TSA
Carcinoma
TSA HGD
![Page 26: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/26.jpg)
Carcinoma
![Page 27: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/27.jpg)
Microvesicular HP
SSP
MLH1-deficient SSP with dysplasia
BRAF-mutated MMR-deficient CRC
BRAF-mutated MMR-proficient CRC
KRAS-mutated MMR-proficient CRC
BRAF-mutated TSA
BRAF-mutated TSA with high grade dysplasia
KRAS-mutated TSA with high grade dysplasia
Normal colonic mucosa
Goblet cell HP
MLH1-proficient SSP with dysplasia
KRAS-mutated TSA
BRAF mutation
BRAF mutationCIMP
KRAS mutation
CIMP-H
MLH1 methylationWNT activation
BRAF serrated pathway KRAS serrated pathway
WNT activationTP53 mutation
CIMP-L
WNT activationTP53 mutation
WNT activationTP53 mutation
15% 5% 10%
![Page 28: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/28.jpg)
Are all CRCs in serrated polyposis serrated neoplasia pathway CRCs?
![Page 29: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/29.jpg)
45 CRCs in serrated polyposis patients
• Median age 58.5 y (18 – 76)
• Females 71%
• 46% BRAF mutation
• 5% KRAS mutation
• 38% MLH1-deficient
Rosty et al. Am J Surg Pathol 2013;37:434-442.
![Page 30: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/30.jpg)
Polyp subtypes in 100 serrated polyposis patients
• CRC more frequent when conventional adenomas present
17%
Rosty et al. Am J Surg Pathol 2012;36:876-882.
![Page 31: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/31.jpg)
2019 WHO criteria
![Page 32: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/32.jpg)
WHO 2010 criteria
Criterion 1At least 5 serrated polyps proximal to the sigmoid colon with at least two ≥ 10 mm
Criterion 2Any number of serrated polyps proximal to the sigmoid colon in an individual who had a first-degree relative with SP
Criterion 3More than 20 serrated polyps of any size but distributed throughout the colon
![Page 33: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/33.jpg)
WHO 2019 revision
• 2010 criterion 2 discarded
• Criteria 1 and 2 in line with phenotypes 1 and 2
![Page 34: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/34.jpg)
![Page 35: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/35.jpg)
WHO 2019 revision
• 2010 criterion 2 discarded
• Criteria 1 and 2 in line with phenotypes 1 and 2
• Distal polyps included in the definition with some restriction for size and number of rectal polyps
![Page 36: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/36.jpg)
WHO 2019 revision
• Polyp count is cumulative over multiple colonoscopies
• Any histological subtype of serrated polyp is included in the final polyp count
Criterion 1At least 5 serrated polyps proximal to the rectum all ≥ 5 mm, with at least two ≥ 10 mm
Criterion 2More than 20 serrated polyps of any size but distributed throughout the large bowel, with at least 5 proximal to the rectum
![Page 37: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/37.jpg)
Summary
• CRC in serrated polyposis are heterogeneous• Within the serrated neoplasia pathway
• Half not from serrated polyps – canonical adenoma carcinoma pathway
![Page 38: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/38.jpg)
Summary
• CRC in serrated polyposis are heterogeneous• Within the serrated neoplasia pathway
• Half not from serrated polyps – canonical adenoma carcinoma pathway
• No firm line between criteria fulfilled or not – continuum
![Page 39: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/39.jpg)
![Page 40: Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome · 2019-04-16 · Pathogenesis of Colorectal Cancer in Serrated Polyposis Syndrome Christophe Rosty Brisbane, QLD,](https://reader035.fdocuments.in/reader035/viewer/2022070800/5f0217df7e708231d402895f/html5/thumbnails/40.jpg)
Summary
• CRC in serrated polyposis are heterogeneous• Within the serrated neoplasia pathway
• Half not from serrated polyps – canonical adenoma carcinoma pathway
• No firm line between criteria fulfilled or not – continuum
• CRC risk stratification needed for recommendation on tailored surveillance intervals• Role of conventional adenomas and advanced polyps